{"clarifying_information": [{"clarifying_question1": "Are you primarily interested in how recombinant antibody technology is used specifically to identify and validate new vaccine antigens (such as in reverse vaccinology or creation of subunit vaccines)?", "clarifying_answer1": {"clarifying_answer": "Yes, I am primarily interested in how recombinant antibody technology is used to identify and validate new vaccine antigens, including its applications in reverse vaccinology and the creation of subunit vaccines."}}, {"clarifying_question2": "Are you seeking information on the clinical applications of recombinant antibodies in immunotherapy, such as in cancer treatment, bispecific antibodies, or therapeutic antibody cocktails?", "clarifying_answer2": {"clarifying_answer": "Yes, I am interested in the clinical applications of recombinant antibodies in immunotherapy, including their roles in cancer treatment, the development and use of bispecific antibodies, and therapeutic antibody cocktails."}}, {"clarifying_question3": "Do you want details regarding advances in recombinant antibody production methods and expression systems, including their advantages over traditional antibody generation for both vaccines and immunotherapies?", "clarifying_answer3": {"clarifying_answer": "Yes, I would like details regarding advances in recombinant antibody production methods and expression systems, and how they offer advantages over traditional antibody generation for both vaccines and immunotherapies."}}], "better_queries_2": {"reformulated1": "How is recombinant antibody technology applied to the identification and validation of novel vaccine antigens, including its specific roles in reverse vaccinology and subunit vaccine development?", "reformulated2": "What are the clinical applications of recombinant antibodies in immunotherapy, particularly in cancer treatment, and how have bispecific antibodies and therapeutic antibody cocktails advanced patient care?", "reformulated3": "What are the recent advances in recombinant antibody production methods and expression systems, and how do these improve upon traditional antibody generation in both vaccine development and immunotherapy applications?"}}
